IMRN
Immuron Ltd
$1.23
-0.03 (-2.38%)
At close · Jul 10
Market Cap
$9.93M
Shares
8,071,202
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.23
Open$1.28
Day$1.19–1.31
52W$0.68–2.39
Avg vol 30d151K
Short int74K · 0.9% float · 2.0d
Short vol32%
Last earningsJun 30, 2022
DataJan 2020–Jul 2026
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+3%
above
Price vs 50-day avg
+13%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
32%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+5%
trailing
6-month return
+15%
trailing
YTD return
+61%
this year
Relative strength
+6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-22% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.91% of float · ▼ -48.4% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 3-yr range
Squeeze score
49
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
10.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+3%
Bullish
Price vs 50-day avg
+13%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
32%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-22% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.91% of float · ▼ -48.4% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 32%
52-wk high $2
vs 200-day avg +3%
vs 50-day avg +13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMRN
this stock
Immuron Ltd
|
$9.93M | +61.2% | — | — | 0.9% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
7
- % held
- 1.1%
- Net QoQ
- -79.6K sh
- Top holder
- MORGAN STANLEY
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMRN | +11.8% | +5.1% | +15.0% | +16.0% | +61.2% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | +10.5% | +1.1% | +5.9% | +14.9% | +50.5% |